# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001140361-25-038031
Filing Date
2025-10-14
Accepted
2025-10-14 07:10:18
Documents
30
Period of Report
2025-10-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | ef20057029_8k.htm iXBRL | 8-K | 79705
2 | EXHIBIT 2.1 | ef20057029_ex2-1.htm | EX-2.1 | 825690
3 | EXHIBIT 99.1 | ef20057029_ex99-1.htm | EX-99.1 | 97628
4 | EXHIBIT 99.2 | ef20057029_ex99-2.htm | EX-99.2 | 31936
5 | EXHIBIT 99.3 | ef20057029_ex99-3.htm | EX-99.3 | 37958
9 |  | ef20057029_ex99-3slide1.jpg | GRAPHIC | 108958
10 |  | ef20057029_ex99-3slide2.jpg | GRAPHIC | 336596
11 |  | ef20057029_ex99-3slide3.jpg | GRAPHIC | 402256
12 |  | ef20057029_ex99-3slide4.jpg | GRAPHIC | 130316
13 |  | ef20057029_ex99-3slide5.jpg | GRAPHIC | 183751
14 |  | ef20057029_ex99-3slide6.jpg | GRAPHIC | 167832
15 |  | ef20057029_ex99-3slide7.jpg | GRAPHIC | 155660
16 |  | ef20057029_ex99-3slide8.jpg | GRAPHIC | 103663
17 |  | ef20057029_ex99-3slide9.jpg | GRAPHIC | 153962
18 |  | ef20057029_ex99-3slide10.jpg | GRAPHIC | 156677
19 |  | ef20057029_ex99-3slide11.jpg | GRAPHIC | 92411
20 |  | ef20057029_ex99-3slide12.jpg | GRAPHIC | 110821
21 |  | ef20057029_ex99-3slide13.jpg | GRAPHIC | 142764
22 |  | ef20057029_ex99-3slide14.jpg | GRAPHIC | 131477
| Complete submission text file | 0001140361-25-038031.txt |  | 4711459

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA | bcrx-20251014.xsd | EX-101.SCH | 3866
7 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | bcrx-20251014_lab.xml | EX-101.LAB | 21967
8 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | bcrx-20251014_pre.xml | EX-101.PRE | 16045
32 | EXTRACTED XBRL INSTANCE DOCUMENT | ef20057029_8k_htm.xml | XML | 4204

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 251389592
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)